Royal Philips NV slumped after the medical-equipment maker’s order intake dropped for a fifth quarter in a row on lower demand in China.

New orders fell 9% in the three months through September in part because of a sweeping corruption probe in China targeting the country’s health-care sector. Product delivery times also dragged longer.

Up Next

Philips Slides as Order Drop Raises Doubts Over Sales Growth